Microarrayed recombinant allergens for diagnosis of allergy

Clinical and Experimental Allergy

Volumn 33, Issue 1, 2003, Pages 7-13

  Harwanegg, C ^a   Laffer, S ^a   Hiller, R ^a   Mueller, M W ^a   Kraft, D ^a   Spitzauer, S ^a   Valenta, Rudolf ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; RECOMBINANT DNA;

ALLERGY; DNA MICROARRAY; HUMAN; PRIORITY JOURNAL; REVIEW; TECHNOLOGY;

ALLERGENS; ANTIGEN-ANTIBODY REACTIONS; HUMANS; HYPERSENSITIVITY; PROTEIN ARRAY ANALYSIS; RECOMBINANT PROTEINS; SEROLOGIC TESTS;

EID: 12244262762     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01550.x     Document Type: Review

References (67)

1. Kay AB. Allergy and Allergic Disease. Oxford: Blackwell Science 1997.
2. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev Immunol 2001; 1:69-75.
3. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of human reaginic antibody. J Immunol 1966; 97:840-5.
4. Johansson SGO, Bennich H. Immunological study of an atypical (myeloma) immunoglobulin. Immunology 1967; 13:381-94.
5. Segal DM, Taurog JD, Metzger H. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci USA 1977; 74:2993-7.
6. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997; 113:196-9.
7. Stingl G, Maurer D. IgE-meditated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int Arch Allergy Immunol 1997; 113:24-9.
8. Henderson LL, Larson JB, Gleich GJ. Maximal rise in IgE antibody following ragweed pollination season. J Allergy Clin Immunol 1975; 55:10-5.
9. Mitterman I, Swoboda I, Pierson E et al. Molecular cloning and characterisation of profiling from tobacco (Nicotiana tabacum): increased profiling expressin during pollen maturation. Plant Mol Biol 1995; 27:13746.
10. van der Veen M J, Mulder M, Witteman AM et al. False positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssimus) allergens. J Allergy Clin Immunol 1996; 98:1028-34.
11. Bousquet J, Valenta R. In vivo and in vitro use of recombinant allergens. ACI Intern 1994; 6:54-9.
12. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558-62.
13. Emanuel MB, Howarth PH. Asthma and anaphylaxis: a relevant model for chronic disease? An historical analysis of directions in asthma research. Clin Exp Allergy 1995; 25:15-26.
14. Blackley CH. Experimental Researches on the Causes and Nature of Catarrhus Aestivus (Hayfever or Hay-Asthma). London: Dawson's of Pall Mall, 1959. Originally published by Bailliere, Tindall Cox, London, 1873.
15. Prausnitz C, Küstner J. Studien über die überempfindlichkeit. Centralbe F Bakt 1 Abt Orig 1921; 86:160-8.
16. Ishizaka K, Ishizaka T. Identification of gamma-E antibodies as a carrier of reaginic activity. J Immunol 1967; 99:1187-98.
17. Wide L, Bennich H, Johansson SG. Diagnosis of allergy by an in vitro test for allergen antibodies. Lancet 1967; 2:1105-7.
18. Platts-Mills TA, Rawle F, Chapman MD. Problems in allergen standardization. Clin Rev Allergy 1985; 3:271-90.
19. Chapman MD, Heymann PW, Wilkins SR, Brown M J, Platts-Mills TA. Monoclonal immunoassays for major dust mite (Dermatophagoides) allergens, Der p I and Der f I, and quantitative analysis of the allergen content of mite and house dust extracts. J Allergy Clin Immunol 1987; 80:184-94.
20. van Ree R. Value of monoclonal antibody-based assay: advantages and drawbacks. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1994; 87:127-35.
21. Valenta R, Kraft D. Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995; 7:751-6.
22. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics and immonotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904.
23. Thomas WR, Smith W. Towards defining the full spectrum of important house dust mite allergens. Clin Exp Allergy 1999; 29:1583-7.
24. Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomes A. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000; 106:409-18.
25. Niederberger V, Pauli G, Grönlund H et al. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen: A quantitative study with sera from different populations. J Allergy Clin Immunol 1998; 102:579-91.
26. Valenta R, Duchene M, Vrtala S et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol 1991; 88:889-94.
27. Valenta R, Vrtala S, Ebner C, Kraft D, Scheiner O. Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. Int Arch Allergy Immunol 1992; 97:287-94.
28. Laffer S, Spitzauer S, Susani M et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996; 98:625-58.
29. Niederberger V, Laffer S, Froschl R et al. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998; 101:258-64.
30. Spitzauer S. Allergy to mammalian proteins: at the borderline between foreign and self? Int Arch Allergy Immunol 1999; 120:259-69.
31. Rodriguez R, Villalba M, Monsalve RI, Batanero E. The spectrum of olive pollen allergens. Int Arch Allergy Immunol 2001; 125:185-95.
32. Crameri R. Recombinant Aspergillus furnigatus allergens: from the nucleofide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115:99-104.
33. King TP, Spangfort MD. Structure and biology of stinging insects venom allergens. Int Arch Allergy Immunol 2000; 123:99-106.
34. Pauli G. Evolution in the understanding of cross-reactivities of respiratory allergens: The role of recombinant allergens. Int Arch Allergy Immunol 2000; 123:183-95.
35. Leiferman KM, Gleich GJ, Jones RT. The cross-reactivity of IgE antibodies with pollen allergens. Analyses of various species of ragweed and other fall weed pollens. J Allergy Clin Immunol 1976; 58:140-8.
36. Ebner C, Hirschwehr R, Bauer L et al. Identification of allergens in fruits and vegetables: IgE cross-reacfivities with important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995; 95:962-9.
37. Hirschwehr R, Valenta R, Ebner C et al. Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol 1992; 90:927-36.
38. Hoffmann-Sommergruber K, O'Riordain G, Ahorn H et al. Molecular charcterization of Dau c 1, the Bet v 1 homologous protein from carrots and its cross-reactivity with Bet v 1 and Api g 1. Clin Exp Allergy 1999; 29:840-7.
39. Breiteneder H, Hoffmann-Sommergruber K, O'Riordain G et al. Molecular charcterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17 kD tree pollen allergens. Eur J Biochem 1995; 233:484-9.
40. Neudecker P, Schweimer K, Nerkamp J et al. Allergic cross-reactivity made visible: solution structure of the major cherry allergen Pru av 1. J Biol Chem 2001; 276:22756-63.
41. Vanek-Krebitz M, Hoffmann-Sommergruber K, Laimer Da Camara Machodo M et al. Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun 1995; 214:538-51.
42. Leitner A, Jensen-Jarolim E, Grimm R et al. Allergen in pepper and paprika. Immunologic investigation of the celery-birch-mugwort-spice syndrome. Allergy 1998; 53:3641.
43. Jensen-Jarolim E, Santner B, Leitner A et al. Bell Peppers (Capsium annuurn) express allergens (profilin, pathogenesis related protein P23 and Bet v 1 depending on the horticultural strain. International Arch Allergy Immunol 1998; 116:103-9.
44. Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T. Development of new IgE reactivities to allergenic components in pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP system. Allergy 2002; 57:423-30.
45. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002; 127:259-68.
46. Valenta R, Vrtala S, Focke-Tejkl M et al. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy. Biol Chem 1999; 380:815-24.
47. Singh MB, de Weerd N, Bhalla PL. Genetically engineered plant allergens with reduced anaphylactic activity. Int Arch Allergy Immunol 1999; 119:75-85.
48. Valenta R, Vrtala S, Focke-Tejkl M et al. Synthetic and genetically engineered allergen derivatives for specific immune therapy of type I allergy. In: Zweiman B, Schwartz LB, eds. Inflammatory Mechanisms. Clinical Allergy and Immunology Vol. 16. New York: Marcel Dekker, 2001:495-517.
49. van Hage-Hamsten M, Kronqvist M, Zetterstrom O et al. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season. J Allergy Clin Immunol 1999; 104:969-77.
50. Pauli G, Purohit A, Oster JP et al. Clinical evaluation of genetically engineered hypoallergenic Bet v 1 derivatives by skin prick and intradermal testing: results obtained in a French Population. Clin Exp Allergy 2000; 30:1076-84.
51. Nopp A, Hallden G, Lundahl J et al. Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v, 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients. J Allergy Clin Immunol 2000; 106:101-9.
52. Arquint O, Helbling A, Crameri R, Ferreira F, Breitenbach M, Pichler WJ. Reduced in vivo allergenicity of Bet v 1 d isoform, a natural component of birch pollen. J Allergy Clin Immunol 1999; 104:123943.
53. Valenta R. The future of antigen-specific immunotherapy of allergy. Nature Rev Immunol 2002; 2:446-53.
54. Hiller R, Laffer S, Harwanegg C et al. Microarrayed allergen molecules: diagnositic gatekeepers for allergy treatment. FASEB J 2002; 16:414-6.
55. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467-70.
56. MacBeath G, Schreiber S. Printing proteins as microarrays for high-throughput function determination. Science 2000; 289:1760-3.
57. Zhu H, Bilgin M, Bangham R et al. Global analysis of protein activities using proteome chips. Science 2001; 293:2101-5.
58. Haab BB, Dunham M J, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2:RESEARCH0004.
59. Abbot A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature 1999; 402:715-20.
60. Humphery-Smith I, Blackstock W. Proteome analysis: genomics via the output rather than the input code. J Protein Chem 1997; 16:53744.
61. Bussow K, Cahill D, Nietfeld W et al. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucl Acids Res 1998; 26:5007-8.
62. Lueking A, Horn M, Eickhoff H, Buessow K, Lehrach H, Walter G. Protein microarrays for gene expression and antibody screening. Anal Biochem 1999; 270:103-11.
63. Ge H. UPA, a universal protein array system for the quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res 2000; 28:e3.
64. Robinson WH, DiGennaro C, Hueber W et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002; 8:295-301.
65. Wiltshire S, O'Malley S, Lambert J et al. Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin Chem 2000; 46:1990-3.
66. Ekins RP. Ligand assays: from electrophoresis to miniaturized microarrays. Clin Chem 1998; 44:2015-30.
67. Schweitzer B, Wiltshire S, Lambert J et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc Natl Acad Sci USA 2000; 97:10113-9.